Canadian Cancer Society and Weston Foundation
John Lenehan MD, Saman Maleki PhD, and Michael Silverman MD
- in collaboration with CRCHUM and Queen's University - $2M for "ME17 Fecal microbiota transplantation (FMT) in combination with immune checkpoint blockade in patients with advanced melanoma: A randomized phase II trial."
